ACSL4 and metabolic dysfunction-associated steatohepatitis: For the “ferroptosis” pathway, expression of seven genes was higher (FTH1, FTL, ASCL6, ACSL4, MAP1LC3A, TFRC, and GSS) and expression of three genes was lower (SLC40A1, CP, and MAP1LC3C) in NASH.